Assessing prescription stimulant use, misuse, and diversion among youth 10-18 years of age.
Assessing prescription stimulant use, misuse, and diversion among youth 10-18 years of age.
复制标题
DOI：
10.1097/yco.0b013e3283642cb6
复制
发表时间：
2013-09
影响因子：
6.9
通讯作者：
Lasopa SO
中科院分区：
文献类型：
--
作者：
Cottler LB;Striley CW;Lasopa SO
评估兴奋剂的医疗和非医疗用途以及转移是一项挑战，特别是对青年人来说，招募方法以及非医疗用途和使用的定义不同。该领域需要廉价、有效且可靠的数据收集方法来了解处方药使用问题。大多数青少年研究都是在学校或网络上进行的，并且是针对青少年进行的。全国青少年处方兴奋剂监测研究 (N-MAPSS) 通过娱乐场所拦截研究，招募了来自美国 10 个城市的城市、农村和郊区的 11,048 名 10 至 18 岁青少年。本综述讨论了该方法的有效性和四个横截面的结果以及样本的代表性。终生使用任何兴奋剂的流行率为 14.8%，其中农村 16 至 18 岁青少年的比例最高。过去 30 天的使用率为 7.3%，其中一半以上 (3.9%) 为非医疗使用。近 12% 的青少年（无论是否使用者）报告称一生中曾使用或使用过处方兴奋剂。由于没有研究关注 10 岁和 11 岁青少年的兴奋剂使用情况，因此这项研究对于未来的比较具有里程碑意义，并提供了独特的抽样和数据收集策略。
Assessing medical and non-medical use of stimulants and diversion is a challenge, especially among youth, with different methods for recruitment, and definitions of non-medical use and use. The field needs inexpensive, yet effective and reliable, methods of data collection to understand the prescription drug use problem. Most studies of youth are school or web-based, and conducted with teens. The National Monitoring of Adolescent Prescription Stimulants Study (N-MAPSS) recruited 11,048 youth 10 to 18 years of age from urban, rural and suburban areas in ten US cities using an entertainment venue intercept study. This review discusses the effectiveness of the method and results from four cross sections as well as the representativeness of the sample. Lifetime prevalence of any stimulant use was 14.8%, with rates highest among rural 16 to 18 year olds. The rate of past 30 day use was 7.3%, with over half (3.9%) non-medical use. Nearly 12% of all youth (whether a user or not) reported lifetime incoming/outgoing diversion of prescription stimulants. Because no study has focused on stimulant use among youth as young as 10 and 11, this study is a landmark for future comparisons and offers a unique strategy for sampling and data collection.